Pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy

Close metadata

Recommended articles:

Prevalence of cognitive impairment in older adults in the Russian Federation. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):5-11

Comparative characteristics of neuropsychological and neurometabolic changes in patients with Alzheimer’s disease and vascular cognitive impairment. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):17-24

Clinical and psychometric characteristics of cognitive and negative disorders in schizophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):64-71

Cognitive impairment in multiple system atrophy — exclusion criteria or an integral part of the clinical picture?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):86-91

Algorithms for the diagnosis and treatment of cognitive impairment and dysphagia in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(4-2):100-107

Molecular Genetic Aspects of Varicose Vein Disease: Modern Concepts. Journal of Venous Disorders. 2024;(1):48-53

Genetic factors in degenerative disc disease. Burdenko's Journal of Neurosurgery. 2024;(2):112-118

Pathogenetic, clinical-diagnostic and therapeutic aspects of premenstrual syndrome. Russian Bulletin of Obstetrician-Gynecologist. 2024;(2):37-42

Morphological features of vasoproliferative tumor of the retina. Russian Journal of Archive of Pathology. 2024;(2):42-50

Clinical and morphological assessment of patients with adenomyosis: own data. Russian Journal of Human Reproduction. 2024;(2):130-135

Objective. Clarification of the pathogenesis of cognitive disorders in patients with Duchenne muscular dystrophy in the clinical laboratory and molecular genetic study. Material and methods. Thirty-six male patients with Duchenne muscular dystrophy (DMD), aged from 5 to 22 years (mean age 13.7 years), were examined. The control group consisted of 30 healthy people (7—22 years old, mean age 13.8). The clinical, molecular-genetic and laboratory study was conducted. The search for mutations in the dystrophin gene was carried out using multiplex PCR and multiplex ligation-dependent probe amplification. The laboratory study included determination of neurotrophins: brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF) and ciliary neurotrophic factor (CNTF) using immunoenzyme method in serum. Results and conclusion. Severe cognitive impairment was found in 33% of patients with DMD. The distribution of mutations in the DMD gene was not uniform, most often the mutations were found in the region from exon 43 to exon 50. Serum concentration of NGF in patients with DMD was higher than in the control group (2391 pg/ml [1587; 4136] and 553 pg / ml [314; 864], respectively (p<0.001)). In the group of patients with cognitive disorders, there was a decreased concentration of BGF (23 670 [21 700; 30 720] pg/ml (p<0.001)). In patients with BGF concentration less than 31 000 pg/ml, the chances of cognitive disorders were more than 10 times higher (p<0.001, odds ratio OR=12.0, 95% CI [1.9—76.4]). Thus, biochemical mechanisms, such as NGF overexpression and BGF deficiency, are involved in the development of cognitive disorders in patients with DMD.

Keywords:

Duchenne muscular dystrophy

cognitive disorders

pathogenesis

mutations in dystrophin gene

brain derived neurotrophic factor (BDNF)

nerve growth factor (NGF)

ciliary neurotrophic factor (CNTF)

immunoenzyme method

blood serum

Authors:

Sokolova M.G.

Mechnikov North-West State Medical University, St. Petersburg, Russia

Lobzin C.V.

Saint-Petersburg

Nikishina O.A.

Mechnikov North-West State Medical University, St. Petersburg, Russia

Kiselev A.V.

N.N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow, Russia

Rezvantsev M.V.

Kirov Military Medical Academy, St. Petersburg, Russia

Litvinenko I.V.

Kafedra nervnykh bolezneĭ i kafedra psikhiatrii Voenno-meditsinskoĭ akademii

SPIN RSCI: 6112-2792
Scopus AuthorID: 35734354000
ResearcherID: F-9120-2013
ORCID: 0000-0001-8988-3011

Gavrichenko A.V.

Mechnikov North-West State Medical University, St. Petersburg, Russia

List of references:

Falzarano MS, Scotton C, Passarelli C, Ferlini A Duchenne Muscular Dystrophy: From Diagnosis to Therapy. Molecules. 2015;20(10):18168-18184. https://doi.org/10.3390/molecules201018168
Leturcq F, Tuffery-Giraud S. Genetics and molecular aspects of dystrophinopathies. Arch Pediatr. 2015;22(12 suppl 1):123-111. (Article in French). https://doi.org/10.1016/S0929-693X(16)30002-1
Péréon Y, Mercier S, Magot A, Péréon Y, Mercier S, Magot A. Duchenne muscular dystrophy pathophysiology. Arch Pediatr. 2015;22(12 suppl 1): 12:18-23. (Article in French). https://doi.org/10.1016/S0929-693X(16)30004-5
Sharma P, Basu S, Mitchell RW, Stelmack GL, Anderson JE, Halayko AJ, Role of dystrophin in airway smooth muscle phenotype, contraction and lung function. PLoS One. 2014;9(7):102737. https://doi.org/10.1371/journal.pone.0102737
Garbincius JF, Michele DE, Garbincius JF, Michele DE. Dystrophin-glycoprotein complex regulates muscle nitric oxide production through mechanoregulation of AMPK signaling. Proc Natl Acad Sci USA. 2015;112(44): 13663-13668. https://doi.org/10.1073. /pnas.1512991112
Fuenzalida M, Espinoza C, Pérez MÁ, Tapia-Rojas C, Cuitino L, Brandan E, Inestrosa NC. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Neurobiol Dis. 2016;86:109-120. https://doi.org/10.1016./j.nbd.2015.11.018
Miranda R, Nudel U, Laroche S, Vaillend C. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71. Neurobiol Dis. 2011;43(1):134-141. https://doi.org/10.1016./j.nbd.2011.02.017
Ricotti V, Jägle H, Theodorou M, Moore AT, Muntoni F, Thompson DA. Ocular and neurodevelopmental features of Duchenne muscular dystrophy: a signature of dystrophin function in the central nervous system. Eur J Hum Genet. 2016;24(4):562-568. https://doi.org/10.1038/ejhg.2015.135
Fujimoto T, Itoh K, Yaoi T, Fushiki S. Somatodendritic and excitatory postsynaptic distribution of neuron-type dystrophin isoform, Dp40, in hippocampal neurons. Biochem Biophys Res Commun. 2014;452(1):79-84. https://doi.org/10.1016/j.bbrc.2014.08.064
Ramelli GP. Dystrobrevin isoform expression in patients with neuromuscular disease. Clin Neuropathol. 2010;29(4):254-261. PMID: 20569677.
Zhong J, Xu T, Chen G, Liao H, Zhang J, Lan D. Genetic analysis of the dystrophin gene in children with Duchenne and Becker muscular dystrophies. Muscle Nerve. 2017;56(1):117-121. https://doi.org/10.1002/mus
Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol. 2003;2(12):731-740. PMID: 14636778.
Kim MJ, Cho SI, Chae JH, Lim BC, Lee JS, Lee SJ, Seo SH, Park H, Cho A, Kim SY, Kim JY, Park SS, Seong MW. Pitfalls of Multiple Ligation-Dependent Probe Amplifications in Detecting DMD Exon Deletions or Duplications. J Mol Diagn. 2016;18(2):253-259. https://doi.org/10.1016/j.jmoldx.2015.11.002
Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, Johnston HM, Buckley MF. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One. 2010;5(1):8803. https://doi.org/10.1371/journal.pone.0008803
Milic Rasic V, Vojinovic D, Pesovic J, Mijalkovic G, Lukic V, Mladenovic J, Kosac A, Novakovic I, Maksimovic N, Romac S, Todorovic S, Savic Pavicevic D. Intellectual ability in the duchenne muscular dystrophy and dystrophin gene mutation location. Balkan J Med Genet. 2015;17(2):25-35. https://doi.org/10.2478/bjmg-2014-0071
Suzuki H, Aoki Y, Kameyama T, Saito T, Masuda S, Tanihata J, Nagata T, Mayeda A, Takeda S, Tsukahara T. Endogenous Multiple Exon Skipping and Back-Splicing at the DMD Mutation Hotspot. Int J Mol Sci. 2016;17(10). pii: E1722. https://doi.org/10.3390/ijms17101722
Anand A, Tyagi R, Mohanty M, Goyal M, Silva KR, Wijekoon N. Dystrophin induced cognitive impairment: mechanisms, models and therapeutic strategies. Ann Neurosci. 2015;22(2):108-118. https://doi.org/10.5214/ans.0972.7531.221210
Nikishina OA, Sokolova MG, Lobzin SV. Testing of complex psychological methods to study cognitive impairment in patients with Duchenna—Bekkera muscular dystrophy. X-th all-Russian scientific-practical with international participation conference «Health is the basis human potential: problems and solutions» November 22—24, 2015. SPb. Accessed December 12, 2015. (In Russ.) http://www.rishchuk.ru/pdf/trudyi-10-vsernpk-s-mezhduchspb2015chast1.pdf
Gibon J, Barker PA, Gibon J, Barker PA. Neurotrophins and Proneurotrophins. Neuroscientist. 2017;1:107-138. https://doi.org/10.1177/1073858417697037
Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, Gallati S, Steinlin M. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011;18(1):90-95. https://doi.org/10.1016/j.jocn.2010.07.118
D’Angelo MG, Lorusso ML, Civati F, Comi GP, Magri F, Del Bo R, Guglieri M, Molteni M, Turconi AC, Bresolin N. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011;45(5):292-299. https://doi.org/10.1016. https://doi.org/10.1016/j.pediatrneurol.2011.08.003
Pane M, Lombardo ME, Alfieri P, D’Amico A, Bianco F, Vasco G, Piccini G, Mallardi M, Romeo DM, Ricotti V, Ferlini A, Gualandi F, Vicari S, Bertini E, Berardinelli A, Mercuri E. Attention deficit hyperactivity disorder and cognitive function in Duchenne muscular dystrophy: phenotype-genotype correlation. J Pediatr. 2012;161(4):705-709. https://doi.org/10.1016/j.jpeds.2012.03.020
Todeschini A, Gualandi F, Trabanelli C, Armaroli A, Ravani A, Fanin M, Rota S, Bello L, Ferlini A, Pegoraro E, Padovani A, Filosto M. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript. Neuromuscul Disord. 2016;26(10):662-665. https://doi.org/10.1016/j.nmd.2016.08.007.2016
Banihani R, Smile S, Yoon G, Dupuis A, Mosleh M, Snider A, McAdam L. Cognitive and Neurobehavioral Profile in Boys With Duchenne Muscular Dystrophy. J Child Neurol. 2015;30(11):1472-1482. https://doi.org/10.1177/0883073815570154
Chamova T, Guergueltcheva V, Raycheva M, Todorov T, Genova J, Bichev S, Bojinova V, Mitev V, Tournev I, Todorova A. Association between loss of dp140 and cognitive impairment in duchenne and becker dystrophies. Balkan J Med Genet. 2013;16(1):21-30. https://doi.org/10.2478/bjmg-2013-0014
Benabdesselam R, Dorbani-Mamine L, Benmessaoud-Mesbah O, Rendon A, Mhaouty-Kodja S, Hardin-Pouzet H. Dp71 gene disruption alters the composition of the dystrophin-associated protein complex and neuronal nitric oxide synthase expression in the hypothalamic supraoptic and paraventricular nuclei. J Endocrinol. 2012;213(3):239-249. https://doi.org/10.1530/JOE-12-0066
Doorenweerd N, Straathof CS, Dumas EM, Spitali P, Ginjaar IB, Wokke BH, Schrans DG, van den Bergen JC, van Zwet EW, Webb A, van Buchem MA, Verschuuren JJ, Hendriksen JG, Niks EH, Kan HE. Reduced cerebral gray matter and altered white matter in boys with Duchenne muscular dystrophy. Ann Neurol. 2014;76(3):403-411. https://doi.org/10.1002/ana.24222
Doorenweerd N, Dumas EM, Ghariq E, Schmid S, Straathof CS, Roest AA, Wokke BH, van Zwet EW, Webb AG, Hendriksen JG, van Buchem MA, Verschuuren JJ, Asllani I, Niks EH, van Osch MJ, Kan HE Decreased cerebral perfusion in Duchenne muscular dystrophy patients. Neuromuscul Disord. 2017;27(1):29-37. https://doi.org/10.1016/j.nmd.2016.10.005
Sokolova MG, Lobzin SV, Rezvantsev MV. Features neurotrophic regulation in patients with 2 type spinal muscular atrophy. Pediatric neurosurgery and neurology. 2015;3(45): 12-19. (In Russ.)
Sokolova MG. Neurotrophins — markers reparative-destructive processes in children with cerebral palsyf. Vestnik SZGMU. 2015;7(1):93-97. (In Russ.)
Sokolova МG. Hyperexpression of nerve growth factor in patients with 2 type spinal muscular atrophy. Eastern-European Scientific Journal. 2015;4:22-27. (In Russ.) https://doi.org/10.12851/EESJ201508C01ART04
Sokolova М, Penniyaynen V, Kipenko A, Aleksandrov N, Dobrota D, Lopatina E. Study of reinnervation process in patients with 2 type of spinal muscular atrophy: clinical experimental study. Activitas Nervosa Superior Rediviva. 2015;5(4):101-104.

Close metadata